david van sickle speaker interview - greygreen | a global ... · disease control and prevention,...
TRANSCRIPT
![Page 1: David van Sickle Speaker Interview - GreyGreen | A Global ... · Disease Control and Prevention, and a Robert Wood Johnson Foundation Health and Society Scholar at the University](https://reader033.vdocument.in/reader033/viewer/2022060213/5f055b997e708231d4129110/html5/thumbnails/1.jpg)
aligninwheretheyexpectdigitalsolutionstobeputtowork.Somedigitalcompanieschannelthemtowardchallengingindividualclinicalcases,whileothersaimtoshifttheoverallpopulationdistribution.Thiscanhavewide-ranginginfluencesonproductandservicedesign,recruitment,enrolment,andongoingsupport…nottomentionpaymentmodels!
WhatareyoumostlookingforwardtoattheDigitalTherapeutics&DigitalMedicineSummit?Thisisanemergingindustrywithenormouspotentialtoimprovemedicaloutcomes.Thesectorcontainsagroupofthoughtfulpeoplewhoareobsessedwiththepromisingyetpuzzlingfutureofhealthcare.Wearebuildingbusinessesthatbydefinitionaretryingtocreatesurplusvalueforsociety.Atthesummittherewillbeagreatmixofleadersfromdigitalcompanies,pharma,biotech’s,investorsandhealthcaresystems.Iamlookingforwardtosharingwiththisgroup,learningfrompeersandcreatingnewconnectionsthatcanleadtofuturecollaborations.
DavidVanSickleCEO&Co-Founder
IndustryExpertInterview:
DavidVanSickleisCEOandCo-FounderofPropellerHealth.DavidwasformerlyanEpidemicIntelligenceServiceOfficerwiththeCenters forDiseaseControlandPrevention,andaRobertWoodJohnsonFoundationHealthandSocietyScholarattheUniversityofWisconsinSchoolofMedicineandPublicHealth.Healsowritesaboutasthmaepidemiology,medicalanthropology,andglobalchronicrespiratorydisease.
Whyaredigitaltherapeuticsanddigitalmedicinegettingalotofattentionrightnow?Avarietyofeffectivetreatmentshaveaccumulated,relativelyunused,inmanytherapeuticareas.Digitalapproacheshaverecentlydrawnalotofattentionbecausetheycanhelpputexistingtreatmentstobetterandmoreproductiveuse.Increasingly,digitalapproachesusecomputingpowertopersonalizetherapy,adaptdosing,andencouragemoreappropriateandeffectivemanagementofdiseases.Inamechanical-sense,theycanalsomaketherapiesbetter-suitedtotheroutinesofdailylifebyincreasingtheirutilityandmaximizingtheirbenefit,whileminimizingtheirdisruption.Thismeanswidespreadchangestotheexperienceofachronicdiseasethroughmakingcareandtreatmentmorepersonal,timely,convenient,affordableandaccessible.
Whatshouldpharma’srolebeinthisecosystem?Webelievepharmaceuticalcompaniescanusedigitaltoolstobuildbetterrelationshipswiththepeopleandphysicianswhousetheirmedicines,andcreatemoreholistic,supportiveandbeneficialtherapeuticofferings.Therefore,digitalcompanionsbecomethephysicalmanifestationofasetofservicesembeddedwiththeyearsofaccumulatedknowledge,learning,andtestingthatcharacterizethesecompanies.
Intherespiratorydiseasespace,alotofactivityissurroundingthepracticaldevelopmentofdrug-digitalpairings.Theserangefromsimplereminderstotechnology-drivenimprovementsindrugdelivery,buttheirgoalisthesame:toimproveoutcomesforpeoplewithasthmaandCOPDbyensuringthatthepeoplewhoareprescribedthesemedicationsactuallybenefitfromusingthem.
Digitalhealthcompaniesworkingwithpharmaalsohavetorememberthattheseareglobalbusinesses.SotheorientationsofpayersandproviderstodigitalproductsinforeignmarketscanbeasimportantastheyaredifferentfromthoseintheU.S.
Howshoulddigitaltherapeuticanddigitalmedicinecompaniesinteractwithpayersandproviders?Oneoftheleastappreciatedchallengesishowtoproductivelyreconciledifferingviewsoftheeligiblepopulation.Payer,providerandpharmaceuticalorganizationsrarely
DavidwillbeshowcasingtheexcitingworkatPropellerHealthattheDigitalTherapeutics&DigitalMedicineSummit2018onFeb27th-28th inSanJose,CA.Hispresentationistitled“DigitalMedicinesandthePersonalFutureCareandTreatmentforChronicRespiratoryDisease
Digital Therapeutics &Digital Medicine Summit 2018 Feb 27th-28th, San Jose, CA
Pioneers Perspectives
www.digitaltxsummit.com